Recommendations for the referral of patients for proton-beam therapy, an Alberta Health Services report: a model for Canada?
Department of Radiation Oncology, Cross Cancer Institute, and Department of Oncology, University of Alberta, Edmonton, AB.
Guideline Utilization Resource Unit, Alberta Health Services, Calgary, AB.
Division of Radiation Oncology, Tom Baker Cancer Centre, and University of Calgary, Calgary, AB.
Division of Neurosurgery, University of Alberta, Edmonton, AB.
- Published Article
Current oncology (Toronto, Ont.)
- Publication Date
Oct 01, 2014
Referral for pbt is recommended for patients who are being treated with curative intent and with an expectation for long-term survival, and who are able and willing to travel abroad to a proton facility. Commonly accepted indications for referral include chordoma and chondrosarcoma, intraocular melanoma, and solid tumours in children and adolescents who have the greatest risk for long-term sequelae. Current data do not provide sufficient evidence to recommend routine referral of patients with most head-and-neck, breast, lung, gastrointestinal tract, and pelvic cancers, including prostate cancer. It is recommended that all referrals be considered by a multidisciplinary team to select appropriate cases.
Report this publication
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
This record was last updated on 04/18/2018 and may not reflect the most current and accurate biomedical/scientific data available from NLM.
The corresponding record at NLM can be accessed at https://www.ncbi.nlm.nih.gov/pubmed/25302033